Company profile
GH Research PLC
NASDAQ:GHRSBiotechnology: Pharmaceutical Preparations
Clinical trials (9)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05800860 | phase2 | completed | 2023-05-24 | 2024-10-04 | GH Research Ireland Limited | A Trial of GH001 in Patients With Treatment-resistant Depression |
| NCT04698603 | phase1_2 | completed | 2019-11-12 | 2021-11-06 | GH Research Ireland Limited | Clinical Study of GH001 in Depression |
| NCT07540494 | phase1 | not_yet_recruiting | 2026-04-01 | 2026-05-01 | GH Research Ireland Limited | Pharmacokinetics and Safety of GH001 Delivered Via a GH001 Aerosol Delivery System in Healthy Subjects |
| NCT06511947 | phase1 | unknown | 2024-08-01 | 2025-02-01 | GH Research Ireland Limited | Pharmacokinetics of GH001 Delivered Via a Proprietary Aerosol Delivery Device in Healthy Subjects |
| NCT05163691 | phase1 | completed | 2021-06-21 | 2021-10-23 | GH Research Ireland Limited | Pharmacokinetics of GH001 in Healthy Volunteers |
FDA applications (0)
No records yet.